Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
Financials
Financial year 2025
VESALE PHARMA WOMAN HEALTH from Eghezée, company number BE0658893086, closed financial year 2025 with a result of € 4,020 after tax. For that financial year VESALE PHARMA WOMAN HEALTH recorded a gross margin of € 4,327 and equity of € -17,173. Compared with financial year 2024, the result moved from € -5,023 to € 4,020. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ -17,173
▲ € 4,020 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,020
▲ still € 5,023 loss in 2024
Profit after tax over the fiscal year.
€ 62,158
▲ € 61,786 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -23,467.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,900
▲ € 4,742 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,374
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -57 | € -20,945 | € -4,706 | € 4,327 | ▲ € 9,033 |
| Profit after taxes | € -630 | € -21,229 | € -5,023 | € 4,020 | ▲ € 9,042 |
| Equity | € 5,059 | € -16,169 | € -21,192 | € -17,173 | ▲ € 4,020 |
| Total debts | € 57 | € 21,961 | € 26,214 | € 79,330 | ▲ 203% |
| Cash | € 466 | € 1,142 | € 372 | € 62,158 | ▲ € 61,786 |
| Retained profit | € -1,141 | € -22,463 | € -27,486 | € -23,467 | ▲ € 4,020 |
| Balance sheet total | € 5,116 | € 5,792 | € 5,022 | € 62,158 | ▲ € 57,136 |
Key figures of VESALE PHARMA WOMAN HEALTH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VESALE PHARMA WOMAN HEALTH?
What happened at VESALE PHARMA WOMAN HEALTH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4,020. filed late Source: NBB ↗
- New establishment in Eghezée. KBO
- Start of the company according to the CBE. KBO
In short
From € 630 loss in 2022 to € 4,020 profit in 2025.
Best year ever: 2025, with € 4,020 profit.
A new publication or filing at VESALE PHARMA WOMAN HEALTH? We notify you, reason included.
Follow VESALE PHARMA WOMAN HEALTHDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VESALE PHARMA WOMAN HEALTH is Vesale Pharma Internationnal SA.
Directors
According to the 2025 annual accounts
Vesale Pharma Internationnal SA
Director · represented by Jehan Lienart van Lidth de Jeude
Establishments
Establishment units
Physical locations of this company
Rue Louis Allaert,Noville 9
5310 Eghezée
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0658.893.086
- VAT number
- BE 0658.893.086
- Registered office
- Rue Louis Allaert,Noville 9, 5310 Eghezée
- Names & denominations
- VESALE PHARMA WOMAN HEALTH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 July 2016
- Peppol
- Active · Active since 5 Feb 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van overige farmaceutische producten
Groothandel in parfumerieën en cosmetica
Vervaardiging van farmaceutische grondstoffen